 NCI-H1650(ICGE-NCI-H1650,IC-82481)
  NCI-H1650(ICGE-NCI-H1650,IC-82481)

Overview
        | Permits and Restrictions | |
|---|---|
| Organism | Homo sapiens, human | 
| Tissue | lung; derived from metastatic site: pleural effusion | 
| Product Format | frozen | 
| Morphology | epithelial | 
| Culture Properties | adherent | 
| Biosafety Level | 1 Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. | 
| Disease | stage 3B,adenocarcinoma; bronchoalveolar carcinoma | 
| Age | 27 years | 
| Gender | male | 
| Ethnicity | Caucasian, White | 
| Storage Conditions | liquid nitrogen vapor phase | 
Properties
        Clinical Data
        
        
	Caucasian, White
	male
	27 years
	The patient was a smoker.
Background
        | Complete Growth Medium | The base medium for this cell line is ATCC-formulated RPMI-1640 Medium, ATCC 30-2001. To make the complete growth medium, add the following components to the base medium: fetal bovine serum (ATCC 30-2020) to a final concentration of 10%. | 
|---|---|
| Subculturing | Volumes are given for a 75 cm2 flask. Increase or decrease the amount of dissociation medium needed proportionally for culture vessels of other sizes. Corning® T-75 flasks (catalog #430641) are recommended for subculturing this product. 
 
					Subcultivation Ratio: A subcultivation ratio of 1:4 to 1:6 is recommended
				 
					Medium Renewal: Every 2 to 3 days
				 | 
| Cryopreservation | 
					Freeze medium: Complete growth medium supplemented with 5% DMSO
				 
					Storage temperature: liquid nitrogen vapor phase
				 | 
| Culture Conditions | 
					Atmosphere: air, 95%; carbon dioxide (CO2), 5%
				 
					Temperature: 37¡ãC
				 | 








